Pamela A McCombe Selected Research

early pregnancy factor

10/2003	Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis.
8/2003	Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobenzene in normal BALB/c mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pamela A McCombe Research Topics

Disease

11	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2017
11	Disease Progression 01/2022 - 12/2010
10	Multiple Sclerosis 08/2020 - 09/2003
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 06/2014 - 05/2005
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2012 - 08/2003
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2020
2	Inflammation (Inflammations) 05/2020 - 10/2012
2	Myasthenia Gravis 08/2019 - 04/2008
2	Ischemic Stroke 04/2014 - 05/2012
1	Cognitive Dysfunction 11/2020
1	Neuromyelitis Optica (Devic's Disease) 05/2020
1	Relapsing-Remitting Multiple Sclerosis 01/2019
1	Dysbiosis 01/2019
1	Hypoxia (Hypoxemia) 04/2014
1	Stroke (Strokes) 05/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2012
1	Infections 06/2011
1	Diabetes Mellitus 04/2008
1	Sjogren's Syndrome (Sjogren Syndrome) 04/2008
1	Guillain-Barre Syndrome 05/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2005
1	Hypersensitivity (Allergy) 08/2003
1	Chronic Progressive Multiple Sclerosis 01/2003

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2003
3	Biological ProductsIBA 07/2017 - 01/2012
3	GangliosidesIBA 06/2011 - 01/2003
2	Superoxide Dismutase-1IBA 01/2020 - 12/2010
2	Interleukin-6 (Interleukin 6)IBA 10/2012 - 05/2012
2	AntigensIBA 01/2012 - 06/2004
2	Myelin Basic ProteinIBA 01/2012 - 10/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2003 - 09/2003
2	early pregnancy factorIBA 10/2003 - 08/2003
1	GlycosaminoglycansIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 01/2022
1	CreatinineIBA 11/2021
1	atibuclimabIBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	GelsolinIBA 11/2020
1	ClusterinIBA 11/2020
1	AutoantibodiesIBA 05/2020
1	Protein AggregatesIBA 01/2020
1	Alanine (L-Alanine)FDA Link 01/2020
1	Amino Acids FDA Link 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	HLA-DR Antigens (HLA-DR)IBA 01/2020
1	Rituximab (Mabthera)FDA Link 08/2019
1	Dimethyl FumarateIBA 01/2019
1	teriflunomideIBA 01/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2014
1	Peptides (Polypeptides)IBA 04/2014
1	AdrenomedullinIBA 04/2014
1	Oral ContraceptivesIBA 04/2013
1	CytokinesIBA 05/2012
1	Interleukin-10 (Interleukin 10)IBA 05/2012
1	EpitopesIBA 06/2011
1	AntibodiesIBA 04/2008
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 11/2006
1	G(M1) GangliosideIBA 05/2005
1	Myelin Proteolipid ProteinIBA 06/2004
1	SteroidsIBA 09/2003
1	Hormones (Hormone)IBA 09/2003
1	Picryl Chloride (Trinitrochlorobenzene)IBA 08/2003
1	G(M3) GangliosideIBA 01/2003

Therapy/Procedure

9	Therapeutics 12/2021 - 04/2013
1	Immunomodulation 01/2020
1	Immunotherapy 01/2019